Brain Scientific (OTCQB: BRSF) is featured in a broadcast released from NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The new audio press release focuses on the 510(k) clearance the U.S. Food and Drug Administration (“FDA”) has given to Brain Scientific’s next-generation NeuroCap(TM) device. The NeuroCap is an advanced clectroencephalogram (“EEG”) electrode array that obtains rapid EEGs in a variety of settings, from routine clinical and research settings to point of contact, where recording of STAT EEGs is needed. BRSF’s proprietary NeuroCap is a disposable, pre-gelled EEG headset with 22 electrodes and 19 active EEG channels. The device can be applied in five minutes and eliminates the time-consuming tasks of head measurement and electrode placement. “We are constantly working on new products for the EEG market,” said Brain Scientific marketing director Irina Nazarova in the press release. “In the new version of NeuroCap, we added Velcro strips for better adhesion. We also expanded the size range by adding an extra small size. And now this device is designed for broader use — in addition to intensive care units and ERs.”
To listed to the Audio Press Release, visit https://ibn.fm/k4zSQ
To view the full press release, visit https://ibn.fm/p6H14
About Brain Scientific
Brain Scientific is a commercial-stage, health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. For more information about this company, please visit www.BrainScientific.com.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork